Structures by: Narasegowda R. S.
Total: 29
Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)- 4-methylhex-4-enoate
C23H31NO7
Acta Crystallographica Section E (2004) 60, 12 o2223-o2224
a=20.784(2)Å b=9.3210(6)Å c=11.9373(11)Å
α=90.00° β=106.719(7)° γ=90.00°
C18H24NO3,Cl
C18H24NO3,Cl
Acta Crystallographica Section E (2004) 60, 12 o2228-o2229
a=12.0767(11)Å b=19.3499(12)Å c=7.8018(7)Å
α=90.00° β=107.482(7)° γ=90.00°
6-fluoro-3-(4-piperidinio)benz[d]isoxazole chloride
C12H14FN2O,Cl
Acta Crystallographica Section E (2005) 61, 2 o356-o358
a=13.020(6)Å b=6.608(3)Å c=15.119(7)Å
α=90.00° β=113.109(7)° γ=90.00°
3-(p-Nitrobenzyl)-1,3-thiazolidine-2,4-dione
C10H8N2O4S
Acta Crystallographica Section E (2005) 61, 2 o245-o246
a=24.321(3)Å b=5.0468(5)Å c=8.6066(8)Å
α=90.00° β=90.00° γ=90.00°
10-Methoxydibenz[b,f]azepine-5-carboxamide
C16H14N2O2
Acta Crystallographica Section E (2005) 61, 6 o1760-o1761
a=8.8003(2)Å b=9.2012(2)Å c=9.3735(3)Å
α=64.6999(16)° β=76.0520(15)° γ=83.7398(18)°
5-aminophthalide
C8H7NO2
Acta Crystallographica Section E (2005) 61, 2 o343-o344
a=4.6858(7)Å b=8.2573(9)Å c=17.627(2)Å
α=90.00° β=90.00° γ=90.00°
5-bromophthalide
C8H5BrO2
Acta Crystallographica Section E (2005) 61, 2 o345-o346
a=15.4063(19)Å b=6.0861(6)Å c=15.4426(16)Å
α=90.00° β=93.950(9)° γ=90.00°
Nipecotic acid hydrochloride
C6H12NO2,Cl
Acta Crystallographica Section E (2005) 61, 3 o763-o764
a=7.2545(10)Å b=7.2018(9)Å c=7.7886(13)Å
α=90.00° β=97.819(12)° γ=90.00°
5-[4'-(Bromomethyl)biphenyl-2-yl]-2-trityl-2H-tetrazole
C33H25BrN4
Acta Crystallographica Section E (2005) 61, 3 o767-o768
a=10.6150(6)Å b=14.9140(5)Å c=17.3961(9)Å
α=90.00° β=102.263(4)° γ=90.00°
4'-[2-Butyl-4-chloro-5-(hydroxyiminomethyl)-1H-imidazol-3-ylmethyl]biphenyl- 2-carbonitrile
C22H21ClN4O
Acta Crystallographica Section E (2005) 61, 3 o714-o715
a=7.6974(6)Å b=7.8682(6)Å c=19.1907(16)Å
α=79.823(6)° β=84.248(7)° γ=64.220(6)°
2,2'-Diaminodibenzyl
C14H16N2
Acta Crystallographica Section E (2005) 61, 4 o843-o845
a=5.4716(4)Å b=12.4800(10)Å c=16.6950(10)Å
α=90.00° β=90.00° γ=90.00°
Thionordazepam
C15H11Cl1N2S1
Acta Crystallographica Section E (2005) 61, 9 o2934-o2936
a=9.993(2)Å b=14.223(3)Å c=10.175(2)Å
α=90.00° β=90.00° γ=90.00°
N-[(2'-Cyanobiphenyl-4-yl)methyl]-L-valine methyl ester hydrochloride
C20H23N2O2,Cl
Acta Crystallographica Section E (2004) 60, 11 o2160-o2162
a=15.6095(8)Å b=6.8297(4)Å c=18.6854(9)Å
α=90.00° β=103.739(4)° γ=90.00°
1-(4-Fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
C15H10FNO
Acta Crystallographica Section E (2004) 60, 12 o2225-o2227
a=14.606(2)Å b=5.8056(6)Å c=27.037(4)Å
α=90.00° β=99.032(11)° γ=90.00°
2,2'-Dipropylmalonic acid
C9H16O4
Acta Crystallographica Section E (2005) 61, 1 o151-o153
a=7.6830(10)Å b=8.5490(10)Å c=9.3820(10)Å
α=76.249(2)° β=70.140(2)° γ=72.355(2)°
2-Butyl-4-chloro-1-(4-nitrobenzyl)-1H-imidazole-5-carboxaldehyde
C15H16ClN3O3
Acta Crystallographica Section E (2004) 60, 12 o2520-o2521
a=8.3007(5)Å b=12.2295(6)Å c=16.5605(10)Å
α=103.420(4)° β=95.561(3)° γ=106.758(3)°
N-Amino-3-methyl-2,3-dihydro-1,3-benzothiazoliminium chloride monohydrate
C8H10N3S,Cl,H2O
Acta Crystallographica Section E (2005) 61, 1 o176-o178
a=21.0397(19)Å b=11.6598(12)Å c=8.6694(8)Å
α=90.00° β=92.935(7)° γ=90.00°
4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide ethyl methyl ketone hemisolvate
C16H14N2O3S,0.5C4H8O
Acta Crystallographica Section E (2005) 61, 1 o179-o181
a=13.0201(14)Å b=7.7930(5)Å c=17.3305(19)Å
α=90° β=94.373(9)° γ=90°
4'-Methylbiphenyl-2-carboxylic acid
C14H12O2
Acta Crystallographica Section E (2005) 61, 4 o939-o940
a=7.5953(15)Å b=14.582(3)Å c=10.616(2)Å
α=90.00° β=90.610(16)° γ=90.00°
4'-(2-Butyl-4-chloro-5-formylimidazol-1-ylmethyl)biphenyl-2-carbonitrile
C22H20ClN3O
Acta Crystallographica Section E (2005) 61, 4 o1193-o1195
a=8.9729(4)Å b=22.6232(9)Å c=9.9288(5)Å
α=90.00° β=106.427(4)° γ=90.00°
4-(2-Chloroethyl)morpholinium chloride
C6H13ClNO,Cl
Acta Crystallographica Section E (2005) 61, 4 o849-o850
a=6.9876(3)Å b=8.1549(4)Å c=8.6495(3)Å
α=63.530(2)° β=85.004(3)° γ=85.179(2)°
(R,S)-3-ethyl 5-methyl 2-(2-ammonioethoxymethyl)4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine- 3,5-dicarboxylate methanesulfonate hydrate
C20H26ClN2O5,CH3O3S,H2O
Acta Crystallographica Section E (2006) 62, 12 o5814-o5816
a=47.656(11)Å b=11.069(2)Å c=9.848(2)Å
α=90.00° β=99.560(6)° γ=90.00°
N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide
C12H9F3N2O2
Acta Crystallographica Section E (2007) 63, 1 o33-o35
a=10.2636(5)Å b=11.5179(6)Å c=10.4182(5)Å
α=90.00° β=102.9440(10)° γ=90.00°
Trityl losartan
C41H37ClN6O
Acta Crystallographica Section C (2004) 60, 11 o821-o823
a=8.6962(3)Å b=20.5493(6)Å c=21.7392(5)Å
α=69.597(2)° β=88.587(2)° γ=78.962(3)°
Perhydro-pyrrolo-benzofuran
C19H27NO3
Acta Crystallographica Section C (2006) 62, 5 o277-o280
a=9.4708(2)Å b=10.2139(2)Å c=10.7512(2)Å
α=105.8040(10)° β=99.1410(10)° γ=116.3200(10)°
Perhydro-pyrrolo-benzofuran
C19H21NO3
Acta Crystallographica Section C (2006) 62, 5 o277-o280
a=7.2348(2)Å b=10.1212(5)Å c=11.6287(6)Å
α=77.031(2)° β=79.285(3)° γ=76.872(3)°
Perhydro-pyrrolo-benzofuran
C18H20N2O3
Acta Crystallographica Section C (2006) 62, 5 o277-o280
a=7.2330(2)Å b=9.8165(3)Å c=11.6008(3)Å
α=78.541(2)° β=78.992(2)° γ=77.3020(10)°
2-butyl-4-chloro-1-(6-methyl-1,3-benzodioxol-5-ylmethyl)-1H-imidazole- 5-carboxaldehyde
C17H19ClN2O3
Acta Crystallographica Section C (2005) 61, 3 o177-o180
a=12.4899(5)Å b=9.4887(3)Å c=14.1018(5)Å
α=90.00° β=94.3190(10)° γ=90.00°
1-(2-bromo-4,5-dimethoxybenzyl)-2-butyl-4-chloro-1H-imidazole-5-carboxaldehyde
C17H20BrClN2O3
Acta Crystallographica Section C (2005) 61, 3 o177-o180
a=8.547(2)Å b=10.308(2)Å c=10.611(2)Å
α=91.654(4)° β=100.667(4)° γ=93.623(3)°